Trillium Asset Management LLC Grows Stake in UnitedHealth Group Incorporated $UNH

Trillium Asset Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.4% during the 2nd quarter, Holdings Channel.com reports. The firm owned 27,873 shares of the healthcare conglomerate’s stock after buying an additional 2,846 shares during the quarter. Trillium Asset Management LLC’s holdings in UnitedHealth Group were worth $8,696,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Nova Wealth Management Inc. lifted its position in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after purchasing an additional 78 shares in the last quarter. Anderson Financial Strategies LLC purchased a new position in UnitedHealth Group during the first quarter valued at $61,000. Finally, Hughes Financial Services LLC bought a new stake in UnitedHealth Group during the first quarter valued at about $64,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $330.56 on Wednesday. The business has a 50 day simple moving average of $344.70 and a two-hundred day simple moving average of $324.06. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market capitalization of $299.43 billion, a PE ratio of 17.25, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the previous year, the firm posted $7.15 earnings per share. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s payout ratio is presently 46.14%.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Piper Sandler decreased their price target on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday, October 28th. Morgan Stanley raised their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Bank of America raised their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, KeyCorp raised their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.